Zevra Therapeutics: Q4 Earnings Snapshot

CELEBRATION, Fla. (AP) — CELEBRATION, Fla. (AP) — Zevra Therapeutics, Inc. (ZVRA) on Thursday reported a loss of $15.2 million in its fourth quarter.

The Celebration, Florida-based company said it had a loss of 40 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The specialty pharmaceutical company posted revenue of $13.2 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $13.4 million.

For the year, the company reported a loss of $46 million, or $1.30 per share. Revenue was reported as $27.5 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up